Hypoglycemia
Hypoglycemia is a common illness that predominantly affects diabetic patients treated with insulin or other hypoglycemic medicines and insulinoma patients. These complications make it more prevalent in neuropathic patients since diabetes is usually comorbid with neuropathy. Hypoglycemia has been shown, in clinical practice, to cause changes in both the CNS and the PNS. The consequences of hypoglycemia complications on severe neuropathy include irritation and a loss of attention, a disturbance of cognitive functioning, convulsions, and unconscious in severe cases.
Hypoglycemia unawareness is a condition that is brought on by autonomic neuropathy. This condition occurs when a person does not experience the symptoms of low blood glucose. In most cases, the first signs of low blood glucose are sensations of lightheadedness, confusion, nausea, nervousness, and irritability. Patients with severe peripheral neuropathy cannot experience these symptoms, which can interfere with addressing and applying the appropriate treatment. In the absence of medication, patients may risk developing severe hypoglycemia, which can lead to complications such as fainting, vulnerability to accidents, and increased risks of dementia over prolonged periods. Because of these, glucose management levels are highly suggested by physicians in lowering the severity of symptoms and slowing the course of neuropathy.
